The p97 ATPase Activity Inhibitor, DBeQ controls the biological activity of p97 ATPase. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
Synonym(s):
p97 ATPase Activity Inhibitor, DBeQ, CID676352, CID16472035, N²,N⁴-Dibenzylquinazolinine-2,4-diamine, KUC105555N, Valosin-containing Protein Inhibitor I, VCP Inhibitor I, ERAD Inhibitor I, p97 Inhibitor I, Valosin-containing Protein Inhibitor I, VCP Inhibitor I, CID676352, CID16472035, N²,N⁴-Dibenzylquinazolinine-2,4-diamine, KUC105555N, ERAD Inhibitor I, p97 Inhibitor I
A cell-permeable quinazolinamine compound that inhibits the AAA (ATPase associated with diverse cellular activities) ATPase p97 (IC50 = 1.6 µM against WT or C522A p97) in a reversible and ATP-competitive (Ki = 3.2 µM) manner, while being at least 50-fold less potent against AAA ATPase NSF (N-methylmaleimide-sensitive factor) or the ATP-dependent chymotrypsin-like activity of proteasome 20S, and exhibiting no significant activity against a panel of ~170 kinases. Shown to effectively suppress p97-dependent cellular processes, including ERAD (ER-associated degradation) reporter TCRα-GFP degradation (92.59% vs. 33.33% degradation in 2 h, respectively, with DMSO or 10 µM DBeQ in HEK293 cultures), autophagic degradation of LC3-II (LC3-II/LC3-I = 0.04 vs. 1.0, respectively, after 3 h DMSO or 10 µM DBeQ treatment in HeLa cultures), UFD (ubiquitin fusion degradation) pathway-mediated UbG76V-GFP reporter degradation (IC50 = 2.3 µM in HeLa cells), but not the degradation of p97-independent proteasome substrates ODC (ornithine decarboxylase) and ODD (oxygen-dependent degradation domain of HIF-1α) luciferase fusion reporters (IC50 = 45 and 56 µM, respectively, in HeLa cells). Also demonstrated to display selective antiproliferative activity against RPMI8226, HeLa, and HEK293 over non-cancerous human fetal lung fibroblasts MRC5 (GI50 = 1.2, 3.1, 4.0, and 6.6 µM, respectively) by inducing cellular DEVD-like (caspase-3/7), but not VEID-like (caspase-6), activity (by 4- to 6-fold in 4 h in HeLa cells) via a yet unknown mechanism.
Packaging
Packaged under inert gas
Warning
Toxicity: Regulatory Review (Z)
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Other Notes
Chou, T.F., et al. 2011. Proc. Natl. Acad. Sci. USA108, 4834.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
